Dublin, Sept. 01, 2020 (GLOBE NEWSWIRE) -- The "North America Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.
The North American digital respiratory solutions market is expected to grow by 34.4% annually in the forecast period and reach $155.05 million by 2030, driven by the rising demand for respiratory aids and air purification amid COVID-19 pandemic.
The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
Highlighted with 24 tables and 39 figures, this 98-page report is based on a comprehensive research of the entire North America digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain.
In-depth qualitative analyses include identification and investigation of the following aspects:
-
Market Structure
-
Growth Drivers
-
Restraints and Challenges
-
Emerging Product Trends & Market Opportunities
-
Porter's Five Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country.
Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Therapeutic Devices
-
Inhalers
-
Nebulizers
Diagnostic Devices
-
Spirometers
-
Asthma Monitors
-
Other Diagnostic Devices
Sensors and Apps
Based on Indication, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
-
Asthma
-
Chronic Obstructive Pulmonary Disease (COPD)
-
COVID-19 Caused Diseases
-
Other Diseases
Based on Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
-
Hospital Pharmacies
-
Retail Pharmacies
-
Online Pharmacies
Geographically, the following national/local markets are fully investigated:
-
U.S.
-
Canada
-
Mexico
For each aforementioned country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America digital respiratory solutions market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players